Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03986762 · ClinicalTrials.gov registry record · Phase 1
Open Label Pharmaco- Magnetic Resonance Spectrography (MRS) Study of Clavulanic Acid
A Phase 1 study of Cocaine-Related Disorders and Cocaine Dependence, in Remission, sponsored by Temple University.
- Completed
- Registry status
- Phase 1
- Development phase
- 9
- Enrollment target
- 1
- Study location
NCT03986762 is a Phase 1 study of Cocaine-Related Disorders and Cocaine Dependence, in Remission that has completed, run by Temple University. The registered enrollment target is 9 participants, below the 64-participant average among 15 other Cocaine-Related Disorders trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03986762, a Phase 1 study of Cocaine-Related Disorders and Cocaine Dependence, in Remission, has completed, sponsored by Temple University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 9 participants
- Enrollment target
- 1
- Study location
Study Summary
The main purpose of this study is to determine how the study drug, clavulanic acid, affects glutamate in the brain using Magnetic Resonance (MR/MRI) scans. In this study, subjects will receive the study drug, clavulanic acid and undergo 4 MRI scans. This is being studied to determine the correct dosing of clavulanic acid, and to gather data so future studies can be done to find out if this drug is helpful in treating cocaine dependence. Currently, there is no available medication treatment for cocaine dependence.
Conditions Studied
Interventions
- DRUG Clavulanic Acid
Study Locations (1)
Pennsylvania
- Episcopal Hospital Medical Arts Building - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2019-03-12 |
| Est. Completion | 2019-12-20 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03986762
The ClinicalTrials.gov registry entry for NCT03986762 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 64-participant average among 15 other Cocaine-Related Disorders trials with a reported enrollment target (86% lower). The listed sponsor is Temple University, which has 163 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Cocaine-Related Disorders appearing as the primary indexed condition, and to 1 intervention - of which Clavulanic Acid is the first listed.
NCT03986762 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03986762 about?
NCT03986762 is a clinical study titled "Open Label Pharmaco- Magnetic Resonance Spectrography (MRS) Study of Clavulanic Acid". The main purpose of this study is to determine how the study drug, clavulanic acid, affects glutamate in the brain using Magnetic Resonance (MR/MRI) scans. In this study, subjects will receive the study drug, clavulanic acid and undergo 4 MRI scans. This is being studied to determine the correct dos...
What is the current status of trial NCT03986762?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 9 participants. The study started on 2019-03-12. Estimated completion is 2019-12-20.
What conditions does trial NCT03986762 study?
This clinical trial studies the following conditions: Cocaine-Related Disorders, Cocaine Dependence, in Remission, Cocaine Abuse, in Remission.
What interventions are being tested in trial NCT03986762?
The interventions under investigation include: Clavulanic Acid (DRUG).
Who is sponsoring clinical trial NCT03986762?
This trial is sponsored by Temple University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03986762 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cocaine-Related Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Treatment of Heroin and Cocaine With Methadone Maintenance and Contingency Management
COMPLETED · Phase 1
-
Cocaethylene as a Treatment for Cocaine Dependence - 1
COMPLETED · Phase 1
-
Effectiveness of N-acetylcysteine in Treating Cocaine Dependent Individuals - 1
COMPLETED · Phase 1
-
Cocaine-Methylphendidate Interaction Study - 4
COMPLETED · Phase 1
-
Prepulse Inhibition of Startle in Cocaine Dependence - 7
COMPLETED · Phase 1
-
Progesterone for the Treatment of Cocaine Dependence - 1
COMPLETED · NA
Explore more on PlainTrial
Cocaine-Related Disorders
All registered trials for this condition
Cocaine Dependence, in Remission
All registered trials for this condition
Pennsylvania
All trials with a study site in Pennsylvania
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.